Aerosol

Imec signs licensing agreement with miDiagnostics to commercialize its patented technology for fast and reliable COVID-19 diagnosis based on exhaled breath

Thursday, October 14, 2021 - 4:39pm

"I note with great pride that we have run an impressive course in the past months," says Luc Van den hove, CEO at imec.

Key Points: 
  • "I note with great pride that we have run an impressive course in the past months," says Luc Van den hove, CEO at imec.
  • "We have succeeded in transforming a promising concept and groundbreaking technology into a functional proof-of-concept that has passed both user tests and clinical studies.
  • This is the first time that we have gone this far in the development of our chip technology towards commercialization.
  • The license agreement with miDiagnostics is an important milestone for imec: Our breakthrough technology will help curb the COVID-19 pandemic in the foreseeable future."

DGAP-News: Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)

Thursday, October 14, 2021 - 2:29pm

Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • Having a global drug development strategy ensures economy of scale and lower cost of drug development to shareholders.
  • The REBORN(c) clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF(TM) to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF(TM) to a late clinical development stage.

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™

Thursday, October 14, 2021 - 11:30am

Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • The Company completed two Phase 1 clinical trials in healthy volunteers to assess the safety profile, including cardiovascular, pharmacodynamics and pharmacokinetics, of smoked and vaporized QIXLEEF.
  • The REBORN clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF to a late clinical development stage.

Smiths Detection confirms BioFlash detects airborne SARS-CoV-2 variants including Delta and Delta plus

Wednesday, October 13, 2021 - 7:00am

Smiths Detection, a global leader in threat detection and security screening technologies, today confirms that its air sampler, BioFlash , can detect SARS-CoV-2 variants including the Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant (B1.617.1), Delta (B.1.617.2) and Delta plus variant (B.1.617.2.1).

Key Points: 
  • Smiths Detection, a global leader in threat detection and security screening technologies, today confirms that its air sampler, BioFlash , can detect SARS-CoV-2 variants including the Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant (B1.617.1), Delta (B.1.617.2) and Delta plus variant (B.1.617.2.1).
  • In January, Smiths Detection announced that BioFlash was capable of detecting airborne SARS-CoV-2 by the United States Army of Medical Research Institute of Infectious Diseases (USAMRIID), and has been successfully used by several Universities to stop the spread of COVID-19 following airborne detection in several campus buildings.
  • Emerging variants are a threat to pandemic recovery; however, mitigation strategies that utilize BioFlash will have an advantage.
  • Smiths Detection, part of Smiths Group, is a global leader in threat detection and screening technologies for aviation, ports and borders, defence and urban security markets.

Cleanfarms Now Collecting Unwanted Agricultural Pesticides and Old Livestock/Equine Medications in Southern Alberta

Monday, October 11, 2021 - 8:23pm

LETHBRIDGE, Alberta, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Cleanfarms is back in southern Alberta holding one-day events in 20 locations from 9 a.m. to 4 p.m., October 25 to 29 to collect unwanted and old agricultural pesticides and obsolete livestock, equine and farm animal medications.

Key Points: 
  • Safely manages and disposes of unused and unwanted agricultural pesticides and obsolete, old livestock, equine and farm animal medications
    LETHBRIDGE, Alberta, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Cleanfarms is back in southern Alberta holding one-day events in 20 locations from 9 a.m. to 4 p.m., October 25 to 29 to collect unwanted and old agricultural pesticides and obsolete livestock, equine and farm animal medications.
  • Cleanfarms operates this program so farmers can dispose of these unwanted materials keeping them out of the environment and managed for safe disposal.
  • Cleanfarms Unwanted Pesticides and Old Livestock/Equine Medications collection program is funded entirely by its crop input members and through a partnership with the Canadian Animal Health Institute (CAHI).
  • Cleanfarms is a national not-for-profit organization that delivers industry-funded, end-of-life stewardship programs to the agricultural sector across Canada.

Delos’ Well Living Lab Introduces Research Agenda to Accelerate Health and Wellness Interventions in Senior Living Environments

Wednesday, October 6, 2021 - 5:30am

The studies will employ the Well Living Labs field study platform, in collaboration with senior living owners and operators, to move its science beyond the walls of the Lab directly into senior living communities.

Key Points: 
  • The studies will employ the Well Living Labs field study platform, in collaboration with senior living owners and operators, to move its science beyond the walls of the Lab directly into senior living communities.
  • Enhancing indoor environments in senior living communities could improve quality of life and longevity as well as increase independence and performance, said Barbara Spurrier, MHA, Executive Director of the Well Living Lab.
  • The forthcoming senior living research will feature similar real-world environmental testing to help identify healthy interventions to improve wellness in this population.
  • The Well Living Lab, founded as a collaboration of Delos and Mayo Clinic, is dedicated to identifying how indoor environments impact human health and well-being.

Worldwide Dimethyl Ether Industry to 2026 - Key Drivers and Restraints - ResearchAndMarkets.com

Friday, October 1, 2021 - 1:20pm

The "Global Dimethyl Ether (DME) Market Outlook to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Dimethyl Ether (DME) Market Outlook to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The report examines the market drivers and restraints and the impact of Covid-19 on the market growth in detail.
  • Therefore, dimethyl ether has met even the most strict emission regulations in U.S.A, Europe, and Japan, making it widely popular as fuel and substitute, thus driving the Global Dimethyl Ether Market.
  • Dimethyl Ether (DME) and Methanol will play an essential role in order to improve the energy security of India.

NASA Awards Sun-Sky Scanning Sun Photometers for the AERONET Project

Thursday, September 30, 2021 - 3:16pm

WASHINGTON, Sept. 30, 2021 /PRNewswire/ -- NASA has awarded a contract for Sun-Sky Scanning Sun Photometers to CIMEL Electronique of Paris, France to support the AErosol RObotic NETwork (AERONET).

Key Points: 
  • WASHINGTON, Sept. 30, 2021 /PRNewswire/ -- NASA has awarded a contract for Sun-Sky Scanning Sun Photometers to CIMEL Electronique of Paris, France to support the AErosol RObotic NETwork (AERONET).
  • These sun photometers monitor aerosol optical properties and provide uniform database for long term characterization of aerosol optical properties within NASA's Global Climate Change program.
  • The AERONET project is a federation of ground-based remote sensing aerosol networks established by NASA and PHOTONS(PHOtomtrie pour le Traitement Oprationnel de Normalisation Satellitaire; Univ.
  • For information about NASA and agency programs, visit:
    View original content to download multimedia: https://www.prnewswire.com/news-releases/nasa-awards-sun-sky-scanning-su...

ClearMask introduces world's first CE-marked, fully transparent surgical mask

Wednesday, September 29, 2021 - 9:00am

BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMask™ is the world's first and only fully transparent surgical mask that is both CE-marked and FDA-cleared. To date, no other transparent masks meet both certifications.

Key Points: 
  • BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMask is the world's first and only fully transparent surgical mask that is both CE-marked and FDA-cleared.
  • The ClearMask transparent surgical mask also passed additional tests in accordance with the transparent mask guidelines released by the United Kingdom, including tests for resistance to penetration of microorganisms (ASTM F1671) and visibility (EN 166).
  • With its fully transparent, anti-fog plastic barrier, the ClearMask brand increases visual communication, which may help avoid costly errors and adverse outcomes.
  • ClearMask continues to fight against the current pandemic and we are here to stay," said Allysa Dittmar, President of ClearMask.

Cleanfarms Now Collecting Unwanted Agricultural Pesticides and Old Livestock/Equine Medications in Northern Saskatchewan

Friday, September 24, 2021 - 10:58pm

MOOSE JAW, Saskatchewan, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Cleanfarms is back in northern Saskatchewan holding one-day events in 20 locations from 9 a.m. to 4 p.m., October 4 to 8 to collect unwanted and old agricultural pesticides and obsolete livestock, equine and farm animal medications.

Key Points: 
  • Safely manages and disposes of unused and unwanted agricultural pesticides and obsolete, old livestock, equine and farm animal medications
    MOOSE JAW, Saskatchewan, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Cleanfarms is back in northern Saskatchewan holding one-day events in 20 locations from 9 a.m. to 4 p.m., October 4 to 8 to collect unwanted and old agricultural pesticides and obsolete livestock, equine and farm animal medications.
  • Cleanfarms operates this program so farmers can dispose of these unwanted materials keeping them out of the environment and managed for safe disposal.
  • Cleanfarms Unwanted Pesticides and Old Livestock/Equine Medications collection program is funded entirely by its crop input members and through a partnership with the Canadian Animal Health Institute (CAHI).
  • Cleanfarms is a national not-for-profit organization that delivers industry-funded, end-of-life stewardship programs to the agricultural sector across Canada.